Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02282020
Title Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum Treatments (SOLO3)
Acronym SOLO3
Recruitment Completed
Gender female
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: child | adult | senior
Covered Countries USA | ITA | ESP | CAN | BEL

Facility Status City State Zip Country Details
Research Site Birmingham Alabama 35233 United States Details
Research Site Mobile Alabama 36604 United States Details
Research Site Sacramento California 95817 United States Details
Research Site San Francisco California 94118 United States Details
Research Site Aurora Colorado 80045 United States Details
Research Site Littleton Colorado 80120 United States Details
Research Site Hartford Connecticut 06106 United States Details
Research Site Fort Gordon Georgia 30905 United States Details
Research Site Covington Louisiana 70433 United States Details
Research Site Towson Maryland 21204 United States Details
Research Site Detroit Michigan 48201 United States Details
Research Site Albany New York 12208 United States Details
Research Site Mineola New York 11501 United States Details
Research Site Chapel Hill North Carolina 27599 United States Details
Research Site Columbus Ohio 43210 United States Details
Research Site Springfield Oregon 97477 United States Details
Research Site Abington Pennsylvania 19001 United States Details
Research Site Knoxville Tennessee 37920 United States Details
Research Site Nashville Tennessee 37232 United States Details
Research Site Bedford Texas 76022 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Milwaukee Wisconsin 53226 United States Details
Research Site Berazategui B1884BBF Argentina Details
Research Site Caba C1280AEB Argentina Details
Research Site Ciudad de Buenos Aires C1180AAX Argentina Details
Research Site Cordoba 5000 Argentina Details
Research Site La Plata B1897GPD Argentina Details
Research Site San Miguel de Tucumán T4000IAK Argentina Details
Research Site Gent 9000 Belgium Details
Research Site Leuven 3000 Belgium Details
Research Site Ijui 98700-000 Brazil Details
Research Site Passo Fundo 99010 260 Brazil Details
Research Site Porto Alegre 90035-003 Brazil Details
Research Site Porto Alegre 90610-000 Brazil Details
Research Site Rio de Janeiro 22793-080 Brazil Details
Research Site Sao Paulo 01246-000 Brazil Details
Research Site Sao Paulo 01317-000 Brazil Details
Research Site São José do Rio Preto 15090-000 Brazil Details
Research Site Toronto Ontario M4N 3M5 Canada Details
Research Site Toronto Ontario M5G 1X6 Canada Details
Research Site Montreal Quebec H2L 4M1 Canada Details
Research Site Hradec Kralove 500 05 Czechia Details
Research Site Ostrava-Poruba 708 52 Czechia Details
Research Site Praha 2 128 08 Czechia Details
Research Site Zlin 762 75 Czechia Details
Research Site Budapest 1088 Hungary Details
Research Site Budapest 1115 Hungary Details
Research Site Budapest 1122 Hungary Details
Research Site Debrecen 4032 Hungary Details
Research Site Győr 9024 Hungary Details
Research Site Miskolc 3526 Hungary Details
Research Site Afula 18101 Israel Details
Research Site Haifa 31096 Israel Details
Research Site Holon 58100 Israel Details
Research Site Jerusalem 9103102 Israel Details
Research Site Jerusalem 91120 Israel Details
Research Site Petah Tikva 4941492 Israel Details
Research Site Ramat Gan 52621 Israel Details
Research Site Rehovot 7661041 Israel Details
Research Site Tel Hashomer 52621 Israel Details
Research Site Tel-Aviv 6423906 Israel Details
Research Site Zerifin 70300 Israel Details
Research Site Meldola 47014 Italy Details
Research Site Messina 98158 Italy Details
Research Site Milano 20132 Italy Details
Research Site Milano 20133 Italy Details
Research Site Milano 20141 Italy Details
Research Site Napoli 80131 Italy Details
Research Site Roma 00144 Italy Details
Research Site Roma 00168 Italy Details
Research Site Goyang-si 10408 Korea, Republic of Details
Research Site Seoul 03080 Korea, Republic of Details
Research Site Seoul 06273 Korea, Republic of Details
Research Site Seoul 06351 Korea, Republic of Details
Research Site Seoul 138-736 Korea, Republic of Details
Research Site Seoul 139-706 Korea, Republic of Details
Research Site Mexico 07760 Mexico Details
Research Site Mexico 6760 Mexico Details
Research Site Oaxaca 68000 Mexico Details
Research Site Gdańsk 80-219 Poland Details
Research Site Grzepnica 72-003 Poland Details
Research Site Lublin 20-090 Poland Details
Research Site Olsztyn 10-561 Poland Details
Research Site Poznan 60-569 Poland Details
Research Site Warszawa 02-781 Poland Details
Research Site Łódź 93-513 Poland Details
Research Site Barcelona 08035 Spain Details
Research Site Barcelona 08036 Spain Details
Research Site Barcelona 08907 Spain Details
Research Site Córdoba 14004 Spain Details
Research Site Gerona 17007 Spain Details
Research Site Granada 18014 Spain Details
Research Site Madrid 28040 Spain Details
Research Site Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field